• Abstract

    Hypertrophic cardiomyopathy is one of the most common inherited genetic disease of myocardium. It is the leading cause of unexpected mortality among young people and athletes. HCM has been regarded as a sarcomere illness for the past few decades, usually with incomplete penetrance and varied expressivity arising from autosomal dominance. For the purpose of risk and treatment stratification, all diagnostic techniques—such as tissue biopsy, genetic counselling, magnetic resonance imaging, transthoracic and transoesophageal echocardiography, heart catheterization, and genetic counselling—must be used. Additionally, each patient's results should be customized based on their genotype and phenotype. About one-third of people have left ventricular outflow tract blockage at rest, and another third may be prompted to develop it. Interstitial fibrosis and myocyte hypertrophy and disarray are among the histological characteristics of HCM. Another common complication of the hypertrophy is left ventricular diastolic dysfunction. The pathogenesis of H.C.M is complex, and its clinical profile is variable. Functional disability resulting from heart failure and stroke (induced by atrial fibrillation) is also attributed to HCM. The goal of the current treatments for HCM, which include medication, myectomy, alcohol septal ablation, and implanted cardiac defibrillators (ICDs) to avoid SCD, is to slow down the disease's progression and relieve symptoms. Multidisciplinary approaches are best suited for the diagnosis and treatment of patients with HCM. More individualized care and better results for this patient population have been made possible by this, as well as the enhanced safety and effectiveness of medicinal, percutaneous, and surgical therapy for HCM. In this review the molecular pathophysiology of HCM will be reviewed in light of current knowledge. In addition, describing how genetic testing is used for diagnosis and outlining the range of clinical manifestations.

  • References

    1. 1. Sakellaropoulos SG, Steinberg BS. Hypertrophic Cardiomyopathy: A Cardiovascular Challenge Becoming a Contemporary Treatable Disease. Cardiol Res. 2023 Aug;14(4):243–9.
    2. He M, Qiu J, Bai Y, Wang Y, Hu M, Chen G. Non-pharmaceutical Interventions for Hypertrophic Cardiomyopathy: A Mini Review. Front Cardiovasc Med. 2021;8:695247.
    3. Teekakirikul P, Zhu W, Huang HC, Fung E. Hypertrophic Cardiomyopathy: An Overview of Genetics and Management. Biomolecules. 2019 Dec 16;9(12):878.
    4. Cureus | Understanding the Genetic and Molecular Basis of Familial Hypertrophic Cardiomyopathy and the Current Trends in Gene Therapy for Its Management | Article [Internet]. [cited 2024 Feb 3]. Available from: https://www.cureus.com/articles/67052-understanding-the-genetic-and-molecular-basis-of-familial-hypertrophic-cardiomyopathy-and-the-current-trends-in-gene-therapy-for-its-management#!/
    5. Gao J, Collyer J, Wang M, Sun F, Xu F. Genetic Dissection of Hypertrophic Cardiomyopathy with Myocardial RNA-Seq. Int J Mol Sci. 2020 Apr 25;21(9):3040.
    6. Gartzonikas IK, Naka KK, Anastasakis A. Current and emerging perspectives on pathophysiology, diagnosis, and management of hypertrophic cardiomyopathy. Hell J Cardiol HJC Hell Kardiologike Epitheorese. 2023;70:65–74.
    7. Cirino AL, Ho C. Hypertrophic Cardiomyopathy Overview. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJ, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993 [cited 2024 Feb 16]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1768/
    8. Davison JE. Advances in diagnosis and management of Pompe disease. J Mother Child. 2020 Oct 2;24(2):3–8.
    9. Litt MJ, Ali A, Reza N. Familial Hypertrophic Cardiomyopathy: Diagnosis and Management. Vasc Health Risk Manag. 2023;19:211–21.
    10. Santini L, Coppini R, Cerbai E. Ion Channel Impairment and Myofilament Ca2+ Sensitization: Two Parallel Mechanisms Underlying Arrhythmogenesis in Hypertrophic Cardiomyopathy. Cells. 2021 Oct 18;10(10):2789.
    11. Cheng Z, Fang T, Huang J, Guo Y, Alam M, Qian H. Hypertrophic Cardiomyopathy: From Phenotype and Pathogenesis to Treatment. Front Cardiovasc Med. 2021;8:722340.
    12. Wolf CM. Hypertrophic cardiomyopathy: genetics and clinical perspectives. Cardiovasc Diagn Ther. 2019 Oct;9(Suppl 2):S388–415.
    13. Mosqueira D, Smith JGW, Bhagwan JR, Denning C. Modeling Hypertrophic Cardiomyopathy: Mechanistic Insights and Pharmacological Intervention. Trends Mol Med. 2019 Sep;25(9):775–90.
    14. Aj M, E B. Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. Circ Res [Internet]. 2017 Sep 15 [cited 2024 Feb 13];121(7). Available from: https://pubmed.ncbi.nlm.nih.gov/28912181/
    15. Firth J. Cardiology: hypertrophic cardiomyopathy. Clin Med. 2019 Jan;19(1):61–3.
    16. Konno T, Chang S, Seidman JG, Seidman CE. Genetics of Hypertrophic Cardiomyopathy. Curr Opin Cardiol. 2010 May;25(3):10.1097/HCO.0b013e3283375698.
    17. Ho CY. Hypertrophic cardiomyopathy. Heart Fail Clin. 2010 Apr;6(2):141–59.
    18. Koshy L, Ganapathi S, Jeemon P, Madhuma M, Vysakh Y, Lakshmikanth LR, et al. Sarcomeric gene variants among Indians with hypertrophic cardiomyopathy: A scoping review. Indian J Med Res. 2023 Aug;158(2):119–35.
    19. Huse S, Acharya S, Agrawal S, J H, Sachdev A, Ghulaxe Y, et al. Recent Advances in Inherited Cardiac Arrhythmias and Their Genetic Testing. Cureus [Internet]. 2023 Oct 25 [cited 2024 Feb 4];15(10). Available from: https://www.cureus.com/articles/190133-recent-advances-in-inherited-cardiac-arrhythmias-and-their-genetic-testing
    20. Lehman SJ, Crocini C, Leinwand LA. Targeting the sarcomere in inherited cardiomyopathies. Nat Rev Cardiol. 2022 Jun;19(6):353–63.
    21. Ribeiro M, Furtado M, Martins S, Carvalho T, Carmo-Fonseca M. RNA Splicing Defects in Hypertrophic Cardiomyopathy: Implications for Diagnosis and Therapy. Int J Mol Sci. 2020 Feb 16;21(4):1329.
    22. Palyam V, Azam AT, Odeyinka O, Alhashimi R, Thoota S, Ashok T, et al. Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Review. Cureus [Internet]. 2022 Jan 11 [cited 2024 Feb 15];14(1). Available from: https://www.cureus.com/articles/82415-hypertrophic-cardiomyopathy-and-atrial-fibrillation-a-review
    23. Fatkin D, Calkins H, Elliott P, James CA, Peters S, Kovacic JC. Contemporary and Future Approaches to Precision Medicine in Inherited Cardiomyopathies: JACC Focus Seminar 3/5. J Am Coll Cardiol. 2021 May 25;77(20):2551–72.
    24. Ellims AH. Hypertrophic cardiomyopathy in the adolescent. Aust Fam Physician. 2017;46(8):553–7.
    25. Santini L, Palandri C, Nediani C, Cerbai E, Coppini R. Modelling genetic diseases for drug development: Hypertrophic cardiomyopathy. Pharmacol Res. 2020 Oct;160:105176.
    26. Maron BJ, Desai MY, Nishimura RA, Spirito P, Rakowski H, Towbin JA, et al. Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022 Feb 1;79(4):390–414.
    27. Tuohy CV, Kaul S, Song HK, Nazer B, Heitner SB. Hypertrophic cardiomyopathy: the future of treatment. Eur J Heart Fail. 2020 Feb;22(2):228–40.
    28. Maron BJ, Desai MY, Nishimura RA, Spirito P, Rakowski H, Towbin JA, et al. Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022 Feb 1;79(4):372–89.
    29. Seferović PM, Polovina M, Bauersachs J, Arad M, Ben Gal T, Lund LH, et al. Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019 May;21(5):553–76.
    30. Liu L, Liu Z, Chen X, He S. Thromboembolism in Patients with Hypertrophic Cardiomyopathy. Int J Med Sci. 2021;18(3):727–35.
    31. Semsarian C, Ingles J, Maron MS, Maron BJ. New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2015 Mar 31;65(12):1249–54.
    32. Chai AC, Cui M, Chemello F, Li H, Chen K, Tan W, et al. Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized mice. Nat Med. 2023 Feb;29(2):401–11.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2024 Multidisciplinary Reviews

How to cite

Sharma, B., & Choudhary, D. K. (2024). Genetic Insights and Clinical Implications of Inherited Hypertrophic Cardiomyopathy: A Comprehensive Review. Multidisciplinary Reviews, (| Accepted Articles). Retrieved from https://malque.pub/ojs/index.php/mr/article/view/2814
  • Article viewed - 40